Titan Pharmaceuticals, Inc. Accounts Receivable
Titan Pharmaceuticals, Inc. had Accounts Receivable of $38.00 thousand as of 2024-09-30, per its 10-Q filed 2025-01-03.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AccountsReceivableNetCurrent · last filed 2025-03-20
- 2024-09-30: Accounts Receivable, after Allowance for Credit Loss, Current $38.00K.
- 2024-06-30: Accounts Receivable, after Allowance for Credit Loss, Current $38.00K.
- 2024-03-31: Accounts Receivable, after Allowance for Credit Loss, Current $134.00K.
- 2023-12-31: Accounts Receivable, after Allowance for Credit Loss, Current $46.00K.
| Period end | Accounts Receivable, after Allowance for Credit Loss, Current | Accounts Receivable, after Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2024-09-30 | $38.00K 10-Q · filed 2025-01-03 | |
| 2024-06-30 | $38.00K 10-Q · filed 2024-08-15 | |
| 2024-03-31 | $134.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $46.00K 10-K · filed 2025-03-20 | |
| 2023-09-30 | $26.00K 10-K · filed 2024-04-01 | |
| 2023-06-30 | $9.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $8.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $36.00K 10-K · filed 2025-03-20 | |
| 2022-09-30 | $49.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $101.00K 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $218.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $112.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $265.00K 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $103.00K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $398.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $884.00K 10-K · filed 2022-03-25 | |
| 2020-09-30 | $423.00K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $1.06M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.55M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $438.00K 10-K · filed 2021-03-31 | $993.00K 10-K · filed 2020-03-30 |
| 2019-09-30 | $775.00K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $1.14M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $2.05M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $1.74M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $682.00K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $189.00K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $27.00K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $65.00K 10-K/A · filed 2019-04-02 | |
| 2017-09-30 | $91.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $87.00K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $1.01M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $3.59M 10-K · filed 2018-04-02 | |
| 2016-09-30 | $5.91M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $4.85M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $4.86M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $4.21M 10-K · filed 2017-03-16 | |
| 2015-09-30 | $3.90M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $4.48M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $3.48M 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $3.97M 10-K · filed 2016-03-15 | |
| 2014-09-30 | $4.14M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $3.74M 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $4.08M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $4.82M 10-K · filed 2015-03-31 | |
| 2013-09-30 | $4.59M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $3.85M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $4.09M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $4.65M 10-K · filed 2014-03-31 | |
| 2012-09-30 | $3.53M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $3.91M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $3.53M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $3.72M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $2.80M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $1.73M 10-Q/A · filed 2011-08-17 | |
| 2010-12-31 | $1.23M 10-K · filed 2012-03-15 |